Cecilia Ann-Christin Malmborg Hager

Title: Cecilia Ann-Christin Malmborg Hager: Innovator in Antibody Polypeptides

Introduction

Cecilia Ann-Christin Malmborg Hager is a prominent inventor based in Helsingborg, Sweden. She has made significant contributions to the field of biotechnology, particularly in the development of antibody polypeptides. With a total of 10 patents to her name, her work has the potential to impact the diagnosis and treatment of various cancers.

Latest Patents

Among her latest patents is an invention that provides antibody polypeptides with binding specificity for prostate-specific antigen (PSA). This invention includes a heavy chain variable region and a light chain variable region that comprise specific amino acid sequences. The use of these antibody polypeptides is aimed at improving the diagnosis and treatment of prostate cancer. Another notable patent focuses on methods of treating IL1RAP associated cancers with antibodies that inhibit the binding of antibody 'CAN04' to human IL1RAP. This invention has implications for the treatment and diagnosis of IL-1 associated diseases, including acute myeloid leukemia and melanoma.

Career Highlights

Cecilia has worked with notable companies such as Cantargia AB and Fredax AB. Her experience in these organizations has contributed to her expertise in the field of antibody research and development.

Collaborations

Cecilia has collaborated with professionals like Kjell Sjöström and Helena Ågerstam, further enhancing her work in the biotechnology sector.

Conclusion

Cecilia Ann-Christin Malmborg Hager is a distinguished inventor whose work in antibody polypeptides is paving the way for advancements in cancer treatment and diagnosis. Her contributions are invaluable to the scientific community and hold promise for future innovations.